CLDICalidi Biotherapeutics, Inc.

NYSE www.calidibio.com


$ 0.21 $ -0.02 (-7.27 %)    

Friday, 14-Jun-2024 09:36:25 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.204
$ 0.21
$ 0.00 x 0
$ 0.00 x 0
$ 0.21 - $ 0.21
$ 0.14 - $ 13.79
795,188
na
7.25M
$ 0.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-15-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-21-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-calidi-biotherapeutics-is-moving-higher-monday

Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors.

Core News & Articles

Calidi Biotherapeutics, Inc. (NYSE:CLDI), a clinical-stage biotechnology company developing a new generation of targeted antitu...

Core News & Articles

Calidi Biotherapeutics Inc. (NYSE:CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation ...

 why-calidi-biotherapeutics-cldi-stock-is-getting-hammered

Calidi Biotherapeutics shares are trading lower by 30.7% during Friday's session. The company announced a definitive agreem...

Core News & Articles

Baird analyst Joel Beatty maintains Calidi Biotherapeutics (AMEX:CLDI) with a Outperform and lowers the price target from $4...